Eurofins to offer biopharma testing in Japan with Astellas lab deal

By Flora Southey contact

- Last updated on GMT

Getty/Laurent Watanabe
Getty/Laurent Watanabe
Astellas will contract out an internal testing laboratory to Eurofins Scientific, marking the CRO’s entry into biopharmaceutical product testing in Japan.

Contract research organisation (CRO) Eurofins has signed an outsourcing agreement with Japanese pharmaceutical company Astellas for one of its testing laboratories in Kyoto.

Astellas’ Analytical Science Laboratories (ASL) offers testing services for raw materials and drug substances, as well as quality evaluation, test method validation, and physicochemical testing.

The laboratory also tests cell based assay for antibodies, offering Eurofins entry into the biopharmaceutical products testing market in Japan.

According to the agreement, Astellas will provide ASL work for “an agreed period of time” ​while Eurofins invests in capabilities and adds staff to the current 140-member workforce.

Eurofins is committed to serving Astellas and its “expanding group of clients in the APAC region,” ​CEO Gilles Martin said in a statement.

The CRO declined a request for additional comment.

The Astellas deal marks Luxembourg-headquartered Eurofins’ latest expansion into the global market. In 2016, the CRO acquired US analytical services firm Advantar Laboratories​, Australian QC company ams​, and Dutch QC services firm Sinensis Life Science.

Last year, the firm bought Canadian drug ingredient manufacturer and testing contractor Alphora Research​ and India-based preclinical CRO Advinus Therapeutics​. And in January this year, Eurofins announced plans to buy UK CRO Selcia​.

Related news

Show more

Related products

show more

What are the building blocks of DCTs?

What are the building blocks of DCTs?

Medable | 26-Apr-2021 | Technical / White Paper

How to create a seamless experience across eConsent, eCOA and more.

Over the past year, tremendous progress was made toward digitizing and...

How a clinical metadata repository helps with data

How a clinical metadata repository helps with data

Formedix | 22-Mar-2021 | Technical / White Paper

This article covers the various ways a clinical metadata repository helps with data quality, and in turn, with data quality in the clinical trials process....

Introduction to eLAS®

Introduction to eLAS®

Clinical Ink | 08-Mar-2021 | Product Brochure

Clinical Ink has developed a unique offering — the electronic Lupus Assessment Suite (eLAS®) to address fundamental challenges impacting systemic lupus...

Related suppliers

Follow us

Products

View more

Webinars